GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar KimLanners (< 20) Submitted: 10/14/2011 8:19:06 PM : Outperform Start Price: $4.01 GTXI Score: -32.54

biotech

Report this Post 1 Comment
Member Avatar bluetune1 (< 20) Submitted: 10/19/2011 12:41:41 AM
Recs: 0

Insiders are buying like crazy...........are they that sure?

Featured Broker Partners


Advertisement